Positive context积极背景
Stocks股票 / Health Care / NEO
NeoGenomics Laboratories, Inc. · Health Care
NEO US listed · USD美股 · 美元
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing.NeoGenomics Laboratories, Inc.，亦称 NeoGenomics 或 Neo，是一家美国CLIA认证的临床实验室、制药服务和信息服务公司，专门从事癌症遗传学诊断检测。
Mid cap中盘 · $2B
Health Care
S&P 600标普600小盘Russell 2000罗素2000
Speculative / unprofitable投机／未盈利
$19.33
-$0.23 · -1.18%
52w low52周低 $6.96high高 $20.29
Extended — wait for a pullback过度拉伸 — 等待回撤
Trend intact — hold; add on dips toward the 10-day average.趋势完好——持有；可在回调至 10 日均线附近时加仓。
As of 2026-09-29截至 2026-09-29
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-09-29
Momentum (RSI 14)动量（RSI 14）
61
Elevated偏高
vs 50-day average相对50日均线
+15.2% above上方
Uptrend intact趋势完好
vs 200-day average相对200日均线
+59.0% above上方
Long trend up长期向上
Volatility波动率
24th percentile第24百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-10-2729
Estimates being cut预期下调
Beat expectations 4 quarters in a row连续 4 季度超预期
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度（近几个季度） · average平均 59.2%
Valuation估值
Roughly fair vs sector相对行业估值合理| Multiple指标 | NEO | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/B市净率 | 2.98x | 3.30 | |
| Earnings yield盈利收益率 | -4.33% | 2.56 | |
| FCF yield自由现金流收益率 | -0.87% | 4.11 |
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。
Financials财务数据
fiscal years财年Revenue营业收入
$727.3M2025
20202025
5-yr growth5年复合增速 10.4%
Free cash flow自由现金流
-$21.8M2025
20202025
Operating margin营业利润率
-15.9%
Balance-sheet quality财务体质 4/9
Bankruptcy risk: grey zone破产风险：灰色区
Return on equity股本回报率 -13%
Clean稳健
Leverage杠杆
Current ratio流动比率4.26
Capital allocation资本配置
Stock-based comp股权薪酬$41.3M
Share count change (1y)股数变化（1年）+0.7%
Debt coming due到期债务
SEC filingsSEC 文件Debt schedule not loaded yet.到期债务尚未加载。
This panel is still catching up to the SEC filings for this listing. Check back soon — nothing is being estimated in its place.本面板仍在同步该证券的 SEC 文件，请稍后再查看；此处不作任何估算替代。
A cash-flow scenario is unavailable until the filing inputs are verified.报告数据核实前，现金流情景暂不可用。
Capital-need coverage is not available for this issuer yet.该发行人的资本需求覆盖信息暂不可用。
Reported facts remain separate from the cash-flow scenario until identity and filing provenance are confirmed.在确认身份与报告来源之前，已披露事实与现金流情景保持分离。
Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径，不构成评级、信号或投资建议。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
NEO daily MACD crossed downNEO 日线MACD下穿
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$0.4M net (0 buyers, 2 sellers)-$0.4M 净值（0 买家，2 卖家）
Signal history信号历史
engine events引擎事件
NEARING A HIGH → UPTREND接近高点 → 上涨趋势
HOLD. Day 10 of the cycle, trend intact above a rising 10-day average, weekly still mixed持有。周期第 10 天，趋势完好并位于向上的 10 日均线之上，周线仍为混合
Sep 25, 2026
NEO daily MACD crossed downNEO 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $19.33.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$19.33。
Sep 24, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Sep 24, 2026
NEO daily MACD crossed upNEO 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $19.56.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$19.56。
Sep 23, 2026
NEO daily MACD crossed downNEO 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $18.36.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$18.36。
Sep 17, 2026
NEO RSI reached overboughtNEO RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $19.89.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$19.89。
Sep 15, 2026
NEO made a new 52-week highNEO 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $18.89.价格创出52周新高 — 全市场关注的动量/趋势极值。$18.89。
Sep 15, 2026
NEO daily MACD crossed upNEO 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $18.89.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$18.89。
Sep 14, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Sep 14, 2026
NEO StochRSI turned up from oversoldNEO StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $18.41.StochRSI重回20上方 — 下行动量趋缓的最早预警。$18.41。
Sep 11, 2026
NEO printed a daily-cycle lowNEO 打出日线周期低点
A confirmed local low — in this cycle framework the highest-odds long-entry window. $17.32.一个已确认的局部低点 — 在本周期框架中做多胜率最高的入场窗口。$17.32。
Showing the last 15 of显示最近15条，共 288 signals条信号
Company profile公司档案
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing.NeoGenomics Laboratories, Inc.，亦称 NeoGenomics 或 Neo，是一家美国CLIA认证的临床实验室、制药服务和信息服务公司，专门从事癌症遗传学诊断检测。
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Profitability盈利能力
Below market低于市场
Quality质量
Below market低于市场
Investment资本投入
Above market高于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Below market低于市场
Short interest空头兴趣
Above market高于市场
Watch items — what could change the story关注项 — 可能改变故事的因素
- Margin compression despite revenue growth
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| Price / Book市净率 | 3.0× | 3.3× | 56% |
| Earnings yield盈利收益率 | -4.3% | 2.6% | 14% |
| Free-cash-flow yield自由现金流收益率 | 0.2% | 5.5% | 10% |
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
96/100 — stronger than most强于多数
vs market, 3 months相对大盘（3个月）
95/100 — stronger than most强于多数
vs market, 6 months相对大盘（6个月）
98/100 — stronger than most强于多数
vs market, 12 months相对大盘（12个月）
96/100 — stronger than most强于多数
Rank in sector行业内排名
#12 / 173
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -2.9% | +1.3% |
| 1 Month近1月 | +11.3% | +0.9% |
| 3 Months近3月 | +36.4% | +6.1% |
| 6 Months近6月 | +168.8% | +22.3% |
| Year to date年初至今 | +64.4% | +13.8% |
| 1 Year近1年 | +145.6% | +18.5% |
| 3 Years近3年 | +57.0% | +87.8% |
Trading information交易信息
Beta vs market贝塔
0.99
Volatility rank波动率分位
24th pctile
Short interest空头占比
12.9% of float
Market cap市值
$2B
EPS (trailing)每股收益
$-0.84
Off 52-week high距52周高点
-2.9%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $444M | $484M | $510M | $592M | $661M | $727M |
| EPS每股收益 | — | — | — | — | — | — |
| Free cash flow自由现金流 | $-28M | $-91M | $-97M | $-31M | $-34M | $-22M |
| Gross margin毛利率 | 41.8% | 38.6% | 36.9% | 41.3% | 43.9% | 43.2% |
| Net margin净利率 | 0.9% | -1.7% | -28.3% | -14.9% | -11.9% | -14.9% |
| FCF margin自由现金流利润率 | -6.2% | -18.8% | -19.0% | -5.2% | -5.2% | -3.0% |
Latest fiscal year最近财年
Gross profit毛利润
$314M
Net income净利润
$-108M
Operating cash flow经营现金流
$5M
Total assets总资产
$1.4B
Shareholder equity股东权益
$837M
Long-term debt长期负债
$342M
Shares outstanding总股本
0.13B
Returns & growth回报与增长
Return on equity股本回报率
-12.9%
Return on assets资产回报率
-7.9%
Debt / assets负债/资产
25.1%
Asset growth资产增速
-17.0%
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量：盈利有现金支撑
- Working capital: working capital roughly in line with sales营运资本：营运资本与销售大致同步
- Pricing power: gross margin +1.4pts over 6 years定价能力：毛利率 6 年上升 1.4 个百分点
- Capital discipline: share count +22.3% over 6 years (dilution)资本纪律：股本 6 年增加 22.3%（稀释）
- Balance sheet: Altman Z 2.92 — grey zone资产负债表：Altman Z 2.92——灰色区
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
61
RSI (2-day)RSI（2日）
57
vs 20-day average相对20日均线
+5.2%
vs 50-day average相对50日均线
+15.2%
vs 200-day average相对200日均线
+59.0%
Golden cross (50>200)金叉（50>200）
in effect生效中
MACDMACD
below signal位于信号线下方
Timeframe alignment多周期共振
Daily日线
momentum down — fresh downturn动能向下——刚刚转弱
3-day3日线
momentum up动能向上
Weekly周线
momentum up动能向上
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range width percentile波幅宽度分位
44/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $-0.01 | $-0.06 | +83.3% |
| Mar 2026 | $-0.06 | $-0.08 | +25.0% |
| Dec 2025 | $0.00 | $-0.05 | +100.0% |
| Sep 2025 | $-0.05 | $-0.07 | +28.6% |
Estimate revisions预期修正
Analysts covering覆盖分析师
9
Estimate direction预期调整方向
mostly cutting多数下调
Estimate change, 90 days预期变化（90天）
-7.2%
Net upgrades, 30 days净上调（30天）
-1
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$0.4M
Insider buyers vs sellers内部人买家vs卖家
0 : 2
Short interest空头占流通盘
12.9%
Days to cover回补天数
11.2
Short interest change空头变化
+6.0%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Seasonality — full detail季节性 — 完整明细
Strongest month最强月份
Jun · 100%
Weakest month最弱月份
Dec · 0%
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 33% | -8.0% | 3 |
| Feb2月 | 33% | -19.3% | 3 |
| Mar3月 | 33% | -1.4% | 3 |
| Apr4月 | 33% | -10.9% | 3 |
| May5月 | 67% | +13.7% | 3 |
| Jun6月 | 100% | +1.7% | 3 |
| Jul7月 | 67% | +6.4% | 3 |
| Aug8月 | 75% | +16.9% | 4 |
| Sep9月 | 25% | -10.6% | 4 |
| Oct10月 | 67% | +14.5% | 3 |
| Nov11月 | 100% | +27.5% | 3 |
| Dec12月 | 0% | -6.7% | 3 |
History is a tendency, not a promise — small samples wobble.历史规律只是倾向而非保证 — 样本少时波动大。
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。